Clinical Research Directory

Inclusion Criteria: \* Patient visiting a GP with complaints related to CVD, * Patient receiving the diagnosis of CVD from the GP during the V0, according to international guidelines and made on a clinical basis, * Patient requiring and agreeing to receive conservative or invasive treatment, * French or Dutch speaking patient, * Patient signed informed consent and agrees to take part in the study and follow-up. Exclusion Criteria: * Patient with coagulation disorders such as thrombophilia and/or taking anticoagulation drugs, * Pregnant or breastfeeding patient, * Patient with severe Peripheral Arterial Occlusive Disease (POAD), with Ankle Brachial Index (ABI) \< 0.8, * Patient with malignancy, * Patient with neurological disorder or dementia, * Patients taking regular treatment for CVD 3 months prior to inclusion (except painkillers or anti-inflammatory drugs if taken for reasons other than CVD), * Patient in any other clinical study for any pharmaceutical product within 4 weeks preceding study inclusion, * Patient with any comorbidity or situation preventing a follow-up of 2 years.